CDER Division of Drug Labeling Compliance
This article was originally published in The Rose Sheet
Executive Summary
Director Richard Chastonay is retiring after about 31 years with FDA. Chastonay, who was appointed director in September 1989, has dealt with many high profile labeling issues, including unproven anti-aging and anti-plaque claims for products